Preclinical study of DNA vaccines targeting SARS-CoV-2
H. Hayashi, J. Sun, Y. Yanagida, T. Otera, R. Kubota-Kotetsu, T. Shioda, C. Ono, Y. Matsuura, H. Arase, S. Yoshida, R. Nakamaru, R. Ide, A. Tenma, S. Kawabata, T. Ehara, , H. Nakagami
This study evaluates a DNA vaccine targeting SARS-CoV-2 Spike protein, showing enhanced humoral and cellular immune responses and neutralizing antibody activity.
bioRxiv · Oct 21, 2020Immunology